title: [Liver damage in lymphoma and its clinical significance].
abstract: The incidence of liver damage was evaluated in 125 patients with lymphoma. The result showed that liver dysfunction was seen in 44 cases and liver involvement in 30 cases. The liver damage due to the drug toxicity was not observed. HBV could cause severe clinical sequelae after chemotherapy in the lymphoma. Patients with liver damage had worse prognosis.
authors.affiliation: Second Affilited Hospital of Fujian Medical Colloge, Quanzhou.
authors.forename: J X
authors.initials: JX
authors.lastname: Pan
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000473:pathology*; D006801:Humans; D007938:Leukemia / Q000188:drug therapy / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy / Q000473:pathology*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin; D003520:Cyclophosphamide